SCM
NBP

Superstring Capital Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Superstring Capital Management’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-139,886
Closed -$529K – 49
2025
Q3 		$529K Buy
+139,886
New +$475K 0.52% 33

Other funds holding NBP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ACM
Ariose Capital Management Central, Hong Kong, Hong Kong $149M AUM 287.58% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Superstring Capital Management's NBP Position: Q4 2025 in Review

Superstring Capital Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q4 2025, closing a stake of 139,886 shares — an estimated $529K sold.

Superstring Capital Management first reported a position in NBP in Q3 2025 and held it in 1 quarter. The position peaked at $529K in Q3 2025. 57 funds tracked by Wall St. Rank hold NBP as of Q4 2025.

  • Superstring Capital Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q4 2025 after selling out during the quarter.
  • Superstring Capital Management sold 139,886 NovaBridge Biosciences American Depositary Shares shares in Q4 2025, an estimated $529K.
  • Superstring Capital Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2025 and held it in 1 quarter.
  • Superstring Capital Management's NovaBridge Biosciences American Depositary Shares position peaked at $529K in Q3 2025.
  • 57 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q4 2025.

Based on Superstring Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.